The IVD Market in Vietnam: Forecasts to 2019

    Published: August 19, 2015 | Price: $1,995.00 – $3,990.00

    The IVD Market in Vietnam presents current analysis of the Vietnamese IVD industry.  Vietnam has demonstrated fast economic growth in recent years. Increases in foreign investment, wages, trade, industrialization and tourism have led to economic growth higher than that of many other economies in Asia.  As a result, IVD companies searching for emerging market areas to pursue growth that is no longer possible in developed nations have targeted Vietnam.  The report takes an in-depth look at the market, providing data...
    IVD in China Market Outlook 2014-2024

    Published: June 11, 2015 | Price: $1,995.00 – $3,995.00

    IVD in China Market Outlook 2014-2024 With a population of more than 1 billion, China is the world’s largest country and therefore also its single largest potential market for goods and services. In the past ten years, China has led all major world economies in the average rate of growth in real GDP, total health expenditures, and government health expenditures. As an in vitro diagnostics (IVD) market, China trails only the populous, developed markets of the United States, western European countries,...
    The Market for In Vitro Diagnostic Tests in Latin America: Forecasts to 2019 (Colombia, Brazil, Peru, Argentina, Chile, Venezuela, Ecuador and Other Nations)

    Published: January 31, 2015 | Price: $1,995.00 – $3,990.00

    The Market for IVD in Latin America The Market for IVD in Latin America is an essential resource for IVD companies seeking market information for developing countries with growing economies. Kalorama Information, and VA Consultadora y Asociados of Argentina have published detailed nation by nation market analysis of the IVD markets in LATAM and thier segment markets. Each country in Latin America is different in terms of their healthcare system, insurance services, laws and industry participants. For this reason, this...
    Physician Office Laboratory (POL) Markets, 3rd Edition (Markets for Office-Based Chemistry, Glucose, Coagulation PT, Autoimmune, HIV, Hep, Cardiac Markers, PSA, Flu, HbA1c, Hematology, FOB and Other Tests)

    Published: August 15, 2014 | Price: $3,995.00 – $7,990.00

    Physician Office Laboratory (POL) Markets, 3rd Edition (Markets for Office-Based Chemistry, Glucose, Coagulation PT, Autoimmune, HIV, Hep, Cardiac Markers, PSA, Flu, HbA1c, Hematology, FOB and Other Tests) Physician office laboratories are a diverse but significant market for IVD products. The range of POLs is vast: Individual physicians may peform in-office pregnancy and glucose tests, run automated CBCs and chemistry panels or perform moderate complexity infectious disease tests using plate immunoassays and molecular assays. This report, Physician Office Laboratory Markets is...
    The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 9th Edition

    Published: August 13, 2014 | Price: $1,995.00 – $3,990.00

    The in vitro diagnostics  (IVD) market attracts considerable interest.  There are hundreds of participating companies, competing in multiple areas of testing.  Each IVD segment could be said to function as an industry in and of itself.  There are companies who specialize in one area and companies who participate across segments.  There are myriad products, from routine blood tests to complicated molecular assays and new sequencing based technologies.  It's often necessary for competitors to know about all of the segments of testing as different technologies can...
    IVD in Singapore and Malaysia

    Published: January 1, 2014 | Price: $1,995.00 – $3,995.00

    IVD in Singapore and Malaysia Regional opportunities are the focus of IVD manufacturers that seek marginal growth. Southeast Asia represents a unique market for healthcare providers and their various business suppliers, including the in vitro diagnostics (IVD) industry. Kalorama details in this report two countries expected to provide business for IVD manufacturers: Singapore and Malaysia. IVD in Singapore and Malaysia contains the following information: Healthcare Statistics for Singapore and Malaysia Significant Hospitals in both countries The Clinical Lab Market in...
    The World Market for Immunoassays

    Published: November 6, 2013 | Price: $3,995.00 – $7,990.00

    The World Market for Immunoassays Visit our Immunoassays curated page for complete industry coverage. The immunoassay market is large and long-established, but at the same time highly competitive. Kalorama Information’s newly published report, The World Market for Immunoassays, describes the opportunities that exist for large IVD companies adopting new strategies and for new entrants to take market share. Immunoassays have been used in clinical laboratory medicine since the 1960s, and are indispensable tools in clinical diagnostics. A wide range of...
    The World Market for Infectious Disease Diagnostic Tests

    Published: October 21, 2013 | Price: $3,995.00 – $7,990.00

    Infectious diseases are among the most challenging issues facing health care delivery systems around the world today. The World Health Organisation estimates that more than 17 million people die of an infectious disease each year, with many of these acquired in hospitals. This Kalorama Information report, The World Market for Infectious Disease Diagnostic Tests, takes a comprehensive look at the markets for companies of testing products that can combat infectious disease threats. One of the Most Dynamic Areas of the...
    IVD in China

    Published: August 5, 2013 | Price: $2,500.00 – $5,000.00

    This report, IVD in China represents Kalorama's complete analysis on the Chinese IVD market.  The report provides an introduction to the healthcare system in China, the results of recent reform efforts, and issues and trends.  Regional breakouts of the Chinese system are provided.  The report describes the role that out-of-pocket expenditures and private concerns play in the delivery of healthcare in the nation. The modern Chinese healthcare market was borne of and continues to be guided by the progressive intentions...
    Cell Phone-Enabled Diagnostics: mHealth Applications in IVD

    Published: August 15, 2012 | Price: $995.00 – $1,995.00

    Mobile health has reached in vitro diagnostics and as this Kalorama report details, may change the industry forever.  Over the years, the introduction of transportable, portable, and handheld instruments has resulted in the migration of clinical lab testing from the central lab to a range of environments including self-testing, community clinics, the workplace, home, disaster care and most recently, retail convenience clinics. In spite of promotional materials that emphasize ease of use, the majority of currently available POC tests require...
    Kalorama 2010 Ultra Diagnostics Research Bundle

    Published: March 1, 2011 | Price: $1,500.00 – $2,500.00

    This bundle provides customers with three of the most intensely researched Kalorama Information reports covering the diagnostic industry authored by Shara Rosen, R.T., M.B.A. in 2010 and 2011 These reports will be provided in one PDF, each with its own table of contents. The bundle allows customers to save almost $4,500 off the cost of the individual reports. THE WORLDWIDE MARKET FOR IN VITRO DIAGNOSTIC TESTS, 7th Edition This 900 page report contains coverage of all segments of In Vitro...
    The Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles)

    Published: February 1, 2010 | Price: $2,500.00 – $5,000.00

    The Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles) Clinical laboratories are an essential part of the health industry. Kalorama Information estimates that approximately 80% of physicians' diagnoses are a result of laboratory tests.he constant pressure to reduce healthcare spending is shifting healthcare utilization in favor of the laboratory, making it an ever more valuable part of the treatment plan. As hospital stays are shortened, contact between the physician and patient is reduced, which places a larger role...
    Veterinary Diagnostics Markets

    Published: October 1, 2009 | Price: $995.00 – $1,990.00

    Diagnostic tests are an essential tool for confirming the health status of animals. The global impact of diseases such as bovine spongiform encephalopathy, foot and mouth disease, and highly pathogenic avian influenza has revealed that diagnostic tests play a key role not only in facilitating safe trade but also in many other areas such as the early detection of new diseases and the control of exotic or enzootic animal diseases. The market emerged from nascence in the early 2000s and...
    H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays)

    Published: May 1, 2009 | Price: $250.00 – $1,600.00

    The outbreak of H1N1 (swine flu) highlighted the public health importance of improved testing techniques and providing market opportunities for manufacturers of diagnostic tests and other products related to the disease. These conclusions and others appear in a new report released from Kalorama Information: Swine Flu Market Alert by Kalorama's lead analyst, Shara Rosen. Regardless of the eventual severity of the epidemic, there will be distinct market impact on both immunoassay and molecular test makers, according to the report. The...
    In Vitro Diagnostics in a Recessionary Economy: IVD Market Forecasts, Analysis and Success Strategies

    Published: May 1, 2009 | Price: $250.00 – $3,395.00

    It is commonly asserted that in vitro diagnostics is a recession-proof industry. Kalorama Information's lead diagnostic analyst Shara Rosen tests that assumption and provides strategic conclusions in Shara Rosen's new report In Vitro Diagnostics in a Recessionary Economy. The economic problems that began slowing the U.S. economy keep spreading, with Europe and Japan following America into recession. The US is experiencing high unemployment rate and increased numbers of uninsured workers. But what impact is the downturn having on in vitro...